New and personalized ventilatory strategies in patients with COVID-19
- PMID: 37332761
- PMCID: PMC10273276
- DOI: 10.3389/fmed.2023.1194773
New and personalized ventilatory strategies in patients with COVID-19
Abstract
Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus and may lead to severe respiratory failure and the need for mechanical ventilation (MV). At hospital admission, patients can present with severe hypoxemia and dyspnea requiring increasingly aggressive MV strategies according to the clinical severity: noninvasive respiratory support (NRS), MV, and the use of rescue strategies such as extracorporeal membrane oxygenation (ECMO). Among NRS strategies, new tools have been adopted for critically ill patients, with advantages and disadvantages that need to be further elucidated. Advances in the field of lung imaging have allowed better understanding of the disease, not only the pathophysiology of COVID-19 but also the consequences of ventilatory strategies. In cases of refractory hypoxemia, the use of ECMO has been advocated and knowledge on handling and how to personalize strategies have increased during the pandemic. The aims of the present review are to: (1) discuss the evidence on different devices and strategies under NRS; (2) discuss new and personalized management under MV based on the pathophysiology of COVID-19; and (3) contextualize the use of rescue strategies such as ECMO in critically ill patients with COVID-19.
Keywords: COVID-19; extracorporeal membrane oxygenation; invasive mechanical ventilation; noninvasive respiratory support; prone position; recruitment maneuvers.
Copyright © 2023 Rodrigues de Moraes, Robba, Battaglini, Pelosi, Rocco and Silva.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(5):1-47. Epub 2010 Apr 1. Ont Health Technol Assess Ser. 2010. PMID: 23074408 Free PMC article.
-
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364. Med Sci Monit. 2020. PMID: 32759887 Free PMC article. Review.
-
Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review.Exp Ther Med. 2021 Nov;22(5):1296. doi: 10.3892/etm.2021.10731. Epub 2021 Sep 14. Exp Ther Med. 2021. PMID: 34630651 Free PMC article.
-
Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic Review and Meta-Analysis.J Intensive Care Med. 2022 Mar;37(3):304-318. doi: 10.1177/08850666211045632. Epub 2021 Oct 12. J Intensive Care Med. 2022. PMID: 34636697
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous